Biology
| Answers | Asked by | Last Answered by | |
| cell based assays | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| nucleic acid purification kits | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| buy cell analysis products | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| enzymes | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| Oxygen Glucose Deprivation Model | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| Technical Methods | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Ion Channel Blockers | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Benign Familial Neonatal Seizures | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Autophagy Assays | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Immunocytochemistry Assays | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Cell-based Assays | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Autophagy Assays | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| fluorescent labeled migrating cells | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| single cell tracking | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| pyroptosis IL-1β detection | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| cell apoptosis services | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| antisense oligonucleotide | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| gene therapy services | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| gene delivery systems | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| gene editing | 4 | 119.237.203.* | 05.22 / ashimagupta02 |
| C. elegans Collagen Deposition | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| Cholesterol Ester Transfer Protein TEST | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| Bromodomain Protein Products | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| C. elegans UV Stress Model | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| C. elegans Quantification | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| C. elegans Chemical Mutagenesis | 4 | 220.246.255.* | 05.22 / ashimagupta02 |
| transcriptional sequencing | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| 16S rDNA discovery | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| shRNA adenovirus production | 3 | 220.246.255.* | 05.22 / ashimagupta02 |
| siRNA construction service | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Microbial Genome Editing | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Metatranscriptomic Sequencing | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Functional Gene Sequencing | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| Metabolic Pathway Synthesis | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| baculovirus production | 3 | 119.237.203.* | 05.22 / ashimagupta02 |
| atac sequence | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| microrna seq | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| transcriptome profiling | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| metagenomics genomic analysis of microbial communities | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| microbial identification | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| genetic diversity in prokaryotes | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| clinical and biological insights from viral genome sequencing | 0 | 220.246.255.* | 04.26 / 220.246.255.* |
| single cell rna sequencing | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| bisulfite sequencing data analysis | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| whole transcriptome rna sequencing | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| whole genome sequencing | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| genetic linkage map | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Development of Bead-Based ELISA | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Development of Direct ELISA | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Pesticide Residue ELISA Testing Service | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| ELISA Testing Services | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Giant Cell Tumor of Bone Assay Kits | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Cutaneous Squamous Cell Carcinoma Assay Kits | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Denosumab ELISA Kit | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Anti-Ipilimumab ELISA Kit | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| BACE1 Antibodies and Antigens | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Aggrecan Antibodies and Antigens | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| CD154 (CD40 ligand, CD40L) Antibodies and Antigens | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| heavy metals in food products | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| drug residue | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| cephalosporin beta lactam | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| fluoroquinolones examples | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| drosophila melanogaster biofilm model | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| streptococcus pneumoniae bacteremia model development | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| antibacterial checkerboard test | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| herpesviruses 2 production service | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| HLA-DPB1 Antibody | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Glu-Glu tag Antibody | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| NPVF Antibody | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Haptoglobin Antibody | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Transcription Factor Analysis | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| statistical analysis service | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Secondary Structure Analysis | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| Protein Structure Modeling | 0 | 58.152.81.* | 04.26 / 58.152.81.* |
| adme prediction | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
| fragment to lead solutions | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
| Phenotype-based high content screening | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
| ligand-based virtual screening in drug discovery | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
| Coronavirus Isothermal Titration Calorimetry | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
| FBDD for COVID-19 | 0 | 2605:e440::2:57...* | 04.26 / 2605:e440::2:57...* |
Current QF Information
- QF Introduction:Questions of Biology
- Questions:
- Answers:
Latest Questions
- baculovirus production
- Metabolic Pathway Synthesis
- Functional Gene Sequencing
- Metatranscriptomic Sequencing
- Microbial Genome Editing
- siRNA construction service
- shRNA adenovirus production
- 16S rDNA discovery
- transcriptional sequencing
- C. elegans Chemical Mutagenesis
- C. elegans Quantification
- C. elegans UV Stress Model
- Bromodomain Protein Products
- Cholesterol Ester Transfer Prote..
- C. elegans Collagen Deposition
